Shenzhen New Industries Biomedical Engineering Co. Ltd. Class ASZSE: 300832

Shenzhen New Industries Biomedical Engineering Co: Revenue up 3.28% in Q3 2025, but net profit down 9.72% as domestic sales declined

· Issued by Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A

Q3 2025 saw modest revenue growth of 3.28% year-over-year, but net profit declined 9.72% as domestic revenue fell and profit margins narrowed. Overseas business and high-end equipment sales provided growth momentum, with automation products gaining traction.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Company analysis

Earlier from Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A

All Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A news releases